Pharma Equity Group Statistics
Total Valuation
Pharma Equity Group has a market cap or net worth of DKK 213.59 million. The enterprise value is 256.61 million.
Market Cap | 213.59M |
Enterprise Value | 256.61M |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Pharma Equity Group has 1.23 billion shares outstanding. The number of shares has increased by 12.08% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.23B |
Shares Change (YoY) | +12.08% |
Shares Change (QoQ) | +0.25% |
Owned by Insiders (%) | 4.08% |
Owned by Institutions (%) | 0.14% |
Float | 894.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 6.87 |
P/TBV Ratio | 17.18 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.33 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 1.69.
Current Ratio | 1.92 |
Quick Ratio | 0.10 |
Debt / Equity | 1.69 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.89 |
Financial Efficiency
Return on equity (ROE) is -75.32% and return on invested capital (ROIC) is -24.77%.
Return on Equity (ROE) | -75.32% |
Return on Assets (ROA) | -22.47% |
Return on Capital (ROIC) | -24.77% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.41% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -57.41% |
50-Day Moving Average | 0.17 |
200-Day Moving Average | 0.25 |
Relative Strength Index (RSI) | 50.96 |
Average Volume (20 Days) | 1,356,584 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.16M |
Pretax Income | -32.86M |
Net Income | -30.81M |
EBITDA | -28.92M |
EBIT | -29.16M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 863,000 in cash and 43.88 million in debt, giving a net cash position of -43.02 million or -0.04 per share.
Cash & Cash Equivalents | 863,000 |
Total Debt | 43.88M |
Net Cash | -43.02M |
Net Cash Per Share | -0.04 |
Equity (Book Value) | 25.90M |
Book Value Per Share | 0.03 |
Working Capital | 29.65M |
Cash Flow
Operating Cash Flow | -18.55M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Pharma Equity Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.08% |
Shareholder Yield | -12.08% |
Earnings Yield | -16.20% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |